首页> 外文期刊>Toxicology and Applied Pharmacology >Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.
【24h】

Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.

机译:使用32P后标记法检测小鼠肝脏中苯巴比妥,多氯联苯和氯丹不形成DNA加合物。

获取原文
获取原文并翻译 | 示例
           

摘要

Phenobarbital (PB), polychlorinated biphenyls (PCBs), and chlordane (CLD) increase liver tumor incidences in rodents, and all are tumor promoters. Most indirect tests for DNA reactivity, including mutagenicity and chromosomal damage, have been negative with these agents. Consequently, the modes of action for tumorigenesis by these compounds are not believed to involve direct DNA reactivity; however, only limited information from direct tests is available for the lack of DNA adduct formation. PB, PCBs, and CLD were tested for DNA adduct formation in the liver of male and female B6C3F1 mice after either single or 2-week dietary exposures. Single gavage dose levels were as follows: PB, 200 mg/kg; PCBs, 50 mg/kg; and CLD, 50 mg/kg. Dietary dose levels were as follows: PB, 1000 ppm; PCBs, 200 ppm and CLD, 200 ppm. Animals were killed 24 h following the end of test-substance administration. DNA was extracted from the liver, and DNA adduct concentrations were enriched using either 1-butanol extraction of adducted nucleotides or nuclease P1 digestion of unadducted nucleotides. Using this protocol, none of the three test compounds produced DNA adducts detected by 32P-postlabeling. Similar negative results were obtained for DNA from the livers of both male and female mice receiving either single or 2-week exposures. The two positive controls, benzidine for the 1-butanol extraction procedure and 2-acetylaminofluorene for the nuclease P1 procedure, showed the expected patterns of DNA adducts. These results support the conclusion that the carcinogenicity of PB, PCBs, and CLD in experimental animals is not the result of direct DNA reactivity, but involves epigenetic mechanisms.
机译:苯巴比妥(PB),多氯联苯(PCBs)和氯丹(CLD)会增加啮齿动物的肝脏肿瘤发生率,它们都是肿瘤的促进剂。这些试剂对DNA反应性的大多数间接测试(包括诱变性和染色体损伤)均呈阴性。因此,据信这些化合物用于肿瘤发生的作用方式不涉及直接的DNA反应性。但是,由于缺乏DNA加合物的形成,只能从直接测试中获得有限的信息。在单次或两周饮食暴露后,测试了PB,PCB和CLD在雄性和雌性B6C3F1小鼠肝脏中DNA加合物的形成。单管饲剂量如下:PB,200 mg / kg;多氯联苯,50 mg / kg;和CLD,50 mg / kg。饮食剂量水平如下:PB,1000 ppm; PCBs为200 ppm,CLD为200 ppm。测试物质给药结束后24小时将动物处死。从肝脏中提取DNA,并使用1-丁醇提取加成核苷酸或通过核酸酶P1消化未加成核苷酸来富集DNA加合物浓度。使用该方案,三种测试化合物均未产生通过32P后标记检测到的DNA加合物。从接受单周或两周暴露的雄性和雌性小鼠的肝脏中获得的DNA相似的阴性结果。两个阳性对照(用于1-丁醇萃取步骤的联苯胺和用于核酸酶P1步骤的2-乙酰氨基芴)显示了DNA加合物的预期模式。这些结果支持以下结论:实验动物中PB,PCB和CLD的致癌性不是直接DNA反应性的结果,而是涉及表观遗传机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号